Varicella-zoster virus T cell tropism and the pathogenesis of skin infection

Current Topics in Microbiology and Immunology

Volumn 342, Issue 1, 2010, Pages 189-209

  Arvin, Ann M ^a   Moffat, Jennifer F ^b   Sommer, Marvin ^a   Oliver, Stefan ^a   Che, Xibing ^a   Vleck, Susan ^a   Zerboni, Leigh ^a   Ku, Chia Chi ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; CHICKENPOX VACCINE; OKA VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CHICKENPOX; DISEASE COURSE; GENE DELETION; GENE FUNCTION; GENE MUTATION; GENE PRODUCT; HERPES VIRUS; HERPES ZOSTER; HUMAN; IMMUNOCOMPROMISED PATIENT; IN VIVO STUDY; INOCULATION; LIVER; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIMARY INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; SENSORY GANGLION; SKIN INFECTION; T LYMPHOCYTE; THYMUS; VARICELLA ZOSTER VIRUS; VIRAL TROPISM; VIRUS GENOME; VIRUS REACTIVATION; VIRUS VIRULENCE; XENOGRAFT; ANIMAL; IMMUNOLOGY; LYMPHOID TISSUE; MOUSE; MOUSE MUTANT; REVIEW; SKIN; VIROLOGY;

HUMAN HERPESVIRUS 3;

ANIMALS; CHICKENPOX; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; LYMPHOID TISSUE; MICE; MICE, SCID; SKIN; SKIN DISEASES, INFECTIOUS; T-LYMPHOCYTES;

EID: 79952054529     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-29     Document Type: Article

References (37)

1. Arvin AM (2001a) Varicella-zoster virus. In: Knipe DM, Howley P (eds) Fields' virology, 4th edn. Lippincott-Williams & Wilkins, Philadelphia, pp 2731-2768
2. Arvin AM (2001b) Varicella vaccine: genesis, attenuation and efficacy. Virology 284:153-158 (Pubitemid 32523217)
3. Arvin AM, Schaap AC, Ku C-C, Jones JO, Sommer M, Zerboni Z (2006) Investigations of the molecular mechanisms of varicella-zoster virus pathogenesis. In: Sandri-Golden R (ed) The alphaherpesviruses. Horizon Press Inc, UK
4. Baiker A, Bagowski C, Ito H, Sommer M, Zerboni L, Fabell K, Hay J, Ruyechan W, Arvin AM (2004) The immediate early 63 protein of varicella-zoster virus: analysis of functional domains required for replication in vitro and for T cell and skin tropism in the SCID hu model in vivo. J Virol 78:1181-1194 (Pubitemid 38095828)
5. Besser J, Sommer MH, Zerboni L, Bagowski C, Ito H, Moffat J, Ku C-C, Arvin AM (2003) Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. J Virol 77:5964-5974 (Pubitemid 36538987)
6. Besser J, Ikoma M, Fabel K, Sommer MH, Zerboni L, Grose C, Arvin AM (2004) Differential requirement for cell fusion and virion formation in varicella-zoster virus infection of skin and T cells. J Virol 78:13293-13305 (Pubitemid 39507834)
7. Che X, Zerboni L, Sommer MH, Arvin AM (2006) Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T-cells in vivo. J Virol 7:3238-3248
8. Che X, Berarducci B, Sommer M, Ruyechan WT, Arvin AM (2007) The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo. J Virol 81:3229-3239 (Pubitemid 46456632)
9. Che X, Reichelt M, Sommer MH, Rajamani J, Zerboni L, Arvin AM (2008) Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection. J Virol 82:5825-5834 (Pubitemid 351822257)
10. Cohen JI, Seidel KE (1993) Generation of VZV and viral mutants from cosmid DNAs: VZV thymidine kinase is not essential for replication in vitro. Proc Natl Acad Sci USA 90:7376-7380 (Pubitemid 23222453)
11. Cohen JI, Krogmann T, Bontems S, Sadzot-Delvaux C, Pesnicak L (2005) Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for replication in vitro are also critical for efficient establishment of latency. J Virol 79: 5069-5077 (Pubitemid 40464257)
12. Cohen J, Straus S, Arvin A (2007) Varicella-zoster virus. In: Knipe DM, Howley P (eds) Fields' virology, 5th edn. Lippincott-Williams & Wilkins, Philadelphia, pp 2547-2586
13. Gershon AA (2001) Live attenuated varicella vaccine. Infect Dis Clin N Am 15:65-81
14. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342:635-645 (Pubitemid 30118417)
15. Jones JO, Arvin AM (2003) Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCID hu skin xenografts in vivo. J Virol 77:1268-1280 (Pubitemid 36055550)
16. Jones JO, Arvin AM (2006) Inhibition of the NF-kB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J Virol 80:5113-5124
17. Kemble GW, Annunziato P, Lungu O, Winter RE, Cha TA, Silverstein SJ, Spaete RR (2000) Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells. J Virol 74:11311-11321 (Pubitemid 32224001)
18. Koropchak CM, Solem S, Diaz PS, Arvin AM (1989) Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization. J Virol 63:2392-2395 (Pubitemid 19107844)
19. Ku C-C, Padilla J, Grose C, Butcher EC, Arvin AM (2002) Tropism of varicella-zoster virus for human tonsillar CD4+ T lymphocytes that express activation, memory and skin homing markers. J Virol 76:11425-11433 (Pubitemid 35231298)
20. Ku C-C, Zerboni L, Ito H, Wallace M, Graham B, Arvin AM (2004) Transport of varicella-zoster virus to skin by infected CD4 T cells and modulation of viral replication by epidermal cell interferon-a. J Exp Med 200:917-925 (Pubitemid 39362927)
21. Ku C-C, Besser J, Abendroth A, Grose C, Arvin AM (2005) Varicella-zoster virus pathogenesis and immunobiology: New concepts emerging from investigations in the SCIDhu mouse model. J Virol 79(5):2651-2658 (Pubitemid 40270543)
22. Mallory S, Sommer M, Arvin AM (1997) Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein conformation and trafficking. J Virol 71:8279-8288 (Pubitemid 27446404)
23. Moffat JF, Stein MD, Kaneshima H, Arvin AM (1995) Tropism of varicella-zoster virus for human CD4+ and CD8+ T-lymphocytes and epidermal cells in SCID-hu mice. J Virol 69:5236-5242
24. Moffat J, Zerboni L, Stein M, Grose C, Kaneshima H, Arvin A (1998a) The attenuation of the vaccine Oka strain of varicella-zoster virus and the role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72:965-974 (Pubitemid 28116874)
25. Moffat JF, Zerboni L, Sommer MH, Heineman TC, Cohen JI, Kaneshima H, Arvin AM (1998b) The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc Natl Acad Sci USA 95:11969-11974
26. Niizuma T, Sommer MH, Ito H, Hinchliffe S, Zerboni L, Arvin AM (2003) Mutational analysis of varicella-zoster virus ORF65 protein and its role in infection of human skin and T cell xenografts in the SCIDhu mouse model. J Virol 77:6062-6065 (Pubitemid 36538996)
27. Oliver SL, Sommer M, Zerboni L, Rajamani J, Grose C, Arvin AM (2009) Mutagenesis of varicella zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo. J Virol 83:7495-7506
28. Sato B, Ito H, Hinchliffe S, Sommer MH, Zerboni L, Arvin AM (2003) Effects of mutations in open reading frames 62 and 71, encoding the immediate early transactivating protein, IE62, of varicella-zoster virus on replication in vitro and in skin xenografts in the SCID-hu mouse. J Virol 77:5607-5620 (Pubitemid 36538953)
29. Schaap A, Fortin J-F, Sommer M, Zerboni L, Stamatis S, Ku C-C, Arvin AM (2005) T cell tropism and the role of ORF66 protein in the pathogenesis of varicella-zoster virus infection. J Virol 79:12921-12933 (Pubitemid 41433211)
30. Schaap-Nutt A, Sommer M, Che X, Zerboni L, Arvin AM (2006) ORF66 protein kinase function is required for T cell tropism of varicella-zoster virus in vivo. J Virol 80:11806-11816 (Pubitemid 44788892)
31. Soong W, Schultz JC, Patera AC, Sommer MH, Cohen JI (2000) Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J Virol 74:1864-1870 (Pubitemid 30434045)
32. Tischer BK, Kaufer BB, Sommer M, Wussow F, Arvin AM, Osterrieder N (2007) A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. J Virol 81:13200-13208 (Pubitemid 350156957)
33. Vleck SE, Oliver SL, Reichelt M, Rajamani J, Zerboni L, Jones C, Zehnder J, Grose C, Arvin AM (2010) Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID Mouse Model. J Virol 84:141-152
34. Zerboni L, Arvin AM (2008) The pathogenesis of varicella zoster virus neurotropism and infection. In: Carol R (ed) Neurotropic viral infections. Cambridge Press, New York, pp 225-250
35. Zerboni L, Hinchliffe S, Sommer MH, Ito H, Besser J, Stamatis S, Cheng J, DiStefano D, Kraiouchkine N, Shaw A, Arvin AM (2005a) Analysis of varicella-zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Virology 332:337-346 (Pubitemid 40136552)
36. Zerboni L, Ku C-C, Jones C, Zehnder J, Arvin AM (2005b) Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci USA 102:6490-6495 (Pubitemid 40617470)
37. Zhang X, Rowe J, Wang W, Sommer M, Arvin A, Moffat J, Zhu H (2007) Genetic analysis of varicella zoster virus ORF0 to 4 using a novel luciferase bacterial artificial chromosome system. J Virol 81:9024-9033 (Pubitemid 47311446)